RODM - Hartford Multifactor Developed Markets (ex-US) ETF
Stock Price: $30.68 USD
0.24 (0.79%)
Updated Apr 21, 2021 4:00 PM EDT - Market closed
Assets | $1.98B |
NAV | $30.63 |
Expense Ratio | 0.29% |
PE Ratio | 14.80 |
Beta (5Y) | 0.80 |
Dividend (ttm) | $0.80 |
Dividend Yield | 2.61% |
Ex-Dividend Date | Dec 23, 2020 |
1-Year Return | - |
Trading Day | April 21 |
Last Price | $30.68 |
Previous Close | $30.44 |
Change ($) | 0.24 |
Change (%) | 0.79% |
Day's Open | 30.35 |
Day's Range | 30.35 - 30.68 |
Day's Volume | 767,180 |
52-Week Range | 21.39 - 30.79 |
Fund Description
The investment seeks to provide investment results that, before fees and expenses, correspond to the total return performance of the Hartford Risk-Optimized Multifactor Developed Markets (ex-US) Index. The fund generally invests at least 80% of its assets in securities included in the index and in depositary receipts representing securities included in the index. The index is designed to address risks and opportunities within developed markets located outside the U.S.
Asset Class Equity | Sector International |
Region Global-Ex-US | Inception Date Feb 25, 2015 |
Exchange NYSEARCA | Ticker Symbol RODM |
Index Tracked Hartford Risk-Optimized Multifactor Developed Markets (ex-US) Index |
Top 10 Holdings
7.17% of assetsName | Symbol | Weight |
---|---|---|
Msci Eafe Jun21 Xnli 20210618 | 603256.SS | 0.80% |
Kuehne + Nagel International AG | KNIN.SW | 0.77% |
Merck KGaA | MRK.DE | 0.75% |
Investor AB B | INVE B.ST | 0.74% |
Koninklijke Ahold Delhaize NV | AD.AS | 0.74% |
Bouygues | EN.PA | 0.69% |
Loblaw Companies Ltd | L.TO | 0.68% |
Roche Holding AG | ROG.SW | 0.68% |
Wesfarmers Ltd | WES.AX | 0.67% |
Novo Nordisk A/S B | NOVO B.CO | 0.67% |
Dividends
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 23, 2020 | $0.389 | Dec 29, 2020 |
Jun 25, 2020 | $0.41 | Jun 30, 2020 |
Dec 20, 2019 | $0.35 | Dec 26, 2019 |
Jun 25, 2019 | $0.479 | Jun 28, 2019 |
Dec 20, 2018 | $0.203 | Dec 26, 2018 |
Jun 21, 2018 | $0.3206 | Jun 26, 2018 |
News
Investors looking for exposure to ex-US developed markets stocks may want to consider putting the benefits of factors on their side, a task made easier by the Hartford Multifactor Developed Markets (ex-...